simvastatin has been researched along with Carcinoma, Epidermoid in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 5 (45.45) | 2.80 |
Authors | Studies |
---|---|
Andrades, E; Bódalo, M; Deza, G; Espadas, G; Gimeno, R; Haro, N; Hernández-Muñoz, I; Pozo, ÓJ; Pujol, RM; Sabidó, E; Segura, S; Toll, A; Torres, P | 1 |
Kou, Y; Li, M; Liu, B; Liu, H; Rong, X; Wang, C; Yang, P; Zhang, Y; Zhou, Q | 1 |
Fregni, G; Galland, S; Letovanec, I; Martin, P; Stamenkovic, I | 1 |
Fan, Y; Gao, K; Luo, S; Sun, C; Wang, H; Wang, T; Xiao, Q; Zhang, L; Zhang, Z | 1 |
Adalsteinsson, JA; Feng, H; Hu, C; Jonasson, JG; Kristjansson, AK; Muzumdar, S; Olafsdottir, GH; Ratner, D; Silverberg, JI; Tryggvadottir, L; Ungar, J; Waldman, R; Wu, R | 1 |
Gehrke, T; Hackenberg, S; Hagen, R; Ickrath, P; Kleinsasser, N; Schendzielorz, P; Scherzad, A | 1 |
Aigner, A; Boehm, A; Dietz, A; Mozet, C; Stoehr, M; Wichmann, G | 1 |
Desai, M; Hedlin, H; Kapphahn, K; Manson, JA; Martin, L; Simon, M; Stefanick, ML; Strickler, H; Tang, JY; Wactawski-Wende, J; Wang, A | 1 |
Gaggioli, C; Hooper, S; Sahai, E | 1 |
Kim, CW; Kim, YN; Li, YC; Park, MJ; Ye, SK | 1 |
Kakehata, S; Maruya, S; Mizukami, H; Myers, JN; Shinkawa, H; Shirasaki, T; Takahata, T; Takeda, I; Yagihashi, S | 1 |
11 other study(ies) available for simvastatin and Carcinoma, Epidermoid
Article | Year |
---|---|
Loss of dyskerin facilitates the acquisition of metastatic traits by altering the mevalonate pathway.
Topics: Carcinoma, Squamous Cell; Cell Cycle Proteins; Humans; Mevalonic Acid; Nuclear Proteins; Phenotype; Simvastatin; Skin Neoplasms | 2023 |
Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal.
Topics: Animals; Apoptosis; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Head and Neck Neoplasms; Humans; Kruppel-Like Transcription Factors; Mice; Mouth Neoplasms; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2023 |
Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cells, Cultured; Chemokine CCL2; Chemokine CCL3; Cytokines; Female; Gene Expression; Humans; Inflammation Mediators; Interleukin-6; Lung Neoplasms; Male; Mesenchymal Stem Cells; Middle Aged; Simvastatin; Tumor Cells, Cultured; Tumor Microenvironment | 2020 |
Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca
Topics: Anoctamin-1; Carcinoma, Squamous Cell; Cell Proliferation; Cells, Cultured; Down-Regulation; Gene Expression Regulation, Neoplastic; HaCaT Cells; Humans; Ion Channel Gating; Mouth Neoplasms; Neoplasm Proteins; Neoplasm Staging; Simvastatin | 2021 |
Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from Iceland.
Topics: Atorvastatin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Case-Control Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iceland; Simvastatin; Skin Neoplasms | 2022 |
Additive antitumor effects of celecoxib and simvastatin on head and neck squamous cell carcinoma in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Interleukin-6; Interleukin-8; Simvastatin; Squamous Cell Carcinoma of Head and Neck | 2017 |
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
Topics: Anticholesteremic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Female; Head and Neck Neoplasms; Humans; KB Cells; Male; Neoplasm Staging; Risk Factors; Simvastatin; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2014 |
Relation of statin use with non-melanoma skin cancer: prospective results from the Women's Health Initiative.
Topics: Age Factors; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Environmental Exposure; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Indoles; Logistic Models; Longitudinal Studies; Lovastatin; Middle Aged; Odds Ratio; Overweight; Prospective Studies; Pyridines; Risk Factors; Simvastatin; Skin Neoplasms; Smoking; Sunlight; Vitamin D; Vitamins; White People | 2016 |
A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion.
Topics: Actomyosin; Carcinoma, Squamous Cell; Extracellular Matrix; Fibroblasts; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Integrin alpha5; Lovastatin; Muscle Contraction; Neoplasm Invasiveness; rab GTP-Binding Proteins; Simvastatin | 2010 |
Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.
Topics: Apoptosis; bcl-X Protein; beta-Cyclodextrins; Breast Neoplasms; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cell Line, Tumor; Cell Survival; Cholesterol; Down-Regulation; Enzyme Activation; ErbB Receptors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Membrane Microdomains; Neoplasms; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Simvastatin | 2006 |
Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells.
Topics: Anticholesteremic Agents; Carcinoma, Squamous Cell; Caspase 3; Cell Proliferation; Cell Survival; Focal Adhesion Kinase 1; G1 Phase; Head and Neck Neoplasms; Humans; Integrin beta1; Mevalonic Acid; Neoplasm Invasiveness; Phosphorylation; Signal Transduction; Simvastatin; Tumor Cells, Cultured | 2007 |